• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis. Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019

tetano

Editor, Senior Moderator
Int J Infect Dis. 2020 Apr 3. pii: S1201-9712(20)30198-3. doi: 10.1016/j.ijid.2020.03.065. [Epub ahead of print]
Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019.


Jin Y[SUP]1[/SUP], Wang M[SUP]1[/SUP], Zuo Z[SUP]1[/SUP], Fan C[SUP]2[/SUP], Ye F[SUP]3[/SUP], Cai Z[SUP]4[/SUP], Wang Y[SUP]1[/SUP], Cui H[SUP]1[/SUP], Pan K[SUP]1[/SUP], Xu A[SUP]5[/SUP].

Author information




Abstract

OBJECTIVE:

To investigate the diagnostic value of serological test and dynamitic variance of serum antibody in coronavirus disease 2019 (COVID-19).
METHODS:

We retrospectively included 43 patients with a laboratory-confirmed infection and 33 patients with suspected infection who were finally excluded. The IgM/IgG titer of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was measured by chemiluminescence immunoassay analysis.
RESULTS:

Compared to molecular detection, the sensitivity of serum IgM and IgG antibodies to diagnose COVID-19 were 48.1% and 88.9%, and the specificity were 100% and 90.9%, respectively. In COVID-19 group, IgM positive rate almost increased first then decreased over time, however, IgG positive rate increased till 100% and was higher than IgM all the time. IgM positive rate and titer were not significantly different before and after viral negative. IgG positive rate was up to 90% and not significantly different before and after viral negative. However, the median titer of IgG after viral negative was twice than that before with significant difference.
CONCLUSION:

Viral serological test is an effective diagnostic means for SARS-CoV-2 infection. The positive rate and titer variance of IgG are higher than that of IgM in COVID-19.
Copyright ? 2020. Published by Elsevier Ltd.



KEYWORDS:

COVID-19; Immunoglobulin G; Immunoglobulin M; SARS-CoV-2; diagnosis; serological test


PMID:32251798DOI:10.1016/j.ijid.2020.03.065
 
Back
Top